Pharmaceutical News

HOUSTON--(BUSINESS WIRE)--SynergenX, alongside its affiliated brands Low T Center and HerKare, today announced the launch of an expanded range of treatment options designed to give patients more flexibility, more choice, and more control over their care. These new offerings will be available across all clinic locations and through select telehealth services as of April, 2026. The expanded lineup introduces new ways to address some of the most common concerns patients face, including low libido,...

MANHASSET, N.Y.--(BUSINESS WIRE)--World-renowned expert in thrombosis and blood clotting, Alex C. Spyropoulos, MD, Professor at the Institute of Health System Science at the Feinstein Institutes for Medical Research and Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, has been selected for a prestigious Fulbright United States Scholar award for the 2026-2027 academic year from the U.S. Department of State and the Fulbright Foreign Scholarship Board...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in digital validation and process lifecycle management, today announced it will kick off its global ValConnect Innovation Day series on May 19, 2026, in Lisbon, Portugal, at the Lux Lisboa Park Hotel. The event will bring together life sciences leaders, industry experts, and customers for a program focused on how organizations are applying artificial intelligence, digital transformation, and modern validation approaches a...

LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to postpone the commencement of the previously announced tender offer to acquire all outstanding shares of Assertio to May 8, 2026. As previously announced on May 4, 2026, Assertio has entered into an amended and restated merger agreement (the “Garda Agreement”) to be acquired by Garda for $21.80...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the acquisition of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). “The Terns acquisition reflects Merck’s continued focus on science‑driven, value‑enhancing business development aimed at bringing meaningful innovation to patients,” said Robert M. Davis, chairman and chief executive officer, Merck. “We believe TERN‑701 has the potential to be...

TEL AVIV, Israel--(BUSINESS WIRE)--Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today announced the appointment of Ruth March, PhD and Paolo Tarantino, MD, PhD to its newly established Biopharma Advisory Board. Dr. Tarantino and Dr. March are the first members of the Advisory Board, with additional experts expected to join in the coming months. The formation of the Advisory Board reflects Ibex’s strategic expansion into biopharma and its commitment to partne...

FOSTER CITY, Calif.--(BUSINESS WIRE)--GLP-1 medicines are being prescribed for weight loss at a scale the healthcare system has never managed before. Clinicians can measure weight loss. What they still cannot see, in any scalable, non-invasive way, is which patients are biologically positioned to respond before treatment begins, or how therapy is changing disease biology once it starts. Hepta today announced data at Digestive Disease Week 2026 showing that a blood-based assay analyzing cell-fre...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--SonoThera to Present Non-Viral RIPPLE™ Platform Data Demonstrating Multi-Tissue Delivery and Gene Expression at ASGCT 2026...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 115,279 equity awards, consisting of 101,931 restricted stock units (“RSUs”) and up to 13,348 performance stock units (“PSUs”), will be granted to 53 recently hired individuals, in each case as an inducement material to their acceptance of employment w...

DOVER, Del. & EPALINGES, Switzerland--(BUSINESS WIRE)--Pilatus Biosciences Announces Formation of Scientific Advisory Board...